Un estudio muy interesante en el que hemos participado para ver la distribución del hongo Candida auris en el mundo

Our recent paper describing the drug resistance profile and genetic diversity of #Candida haemulonii species complex. Emergent species closely related to #Candidaauris, often multidrug-resistant and capable of causing outbreaks in healthcare settings. frontiersin.org/article/10.338…

We have a new PNASNews article out: "HGT in the human and skin commensal Malassezia: A bacterially derived flavohemoglobin is required for NO resistance and host interaction" Congratulations Giuseppe Ianiri ! pnas.org/content/early/…

Me, Jose F. Muñoz and Dr Ryan Ames are putting together a special issue for Microorganisms MDPI on Genome Evolution in Fungal pathogens. Deadline 30th Dec. More info: bit.ly/2BXq8IY

Interested in mining #secondary #metabolism from #fungi?Lots of opportunities for #fungal biologists interested in strain genetic engineering and for natural product / medicinal chemists at LifeMine Therapeutics. Check it out! lifeminetx.com/opportunities-…

Candida auris has more up its sleeve: preprint of our latest study at the Patrick Van Dijck lab in collaboration with Christina Cuomo and Jose F. Muñoz is available bioRxiv Microbiology. disq.us/t/3ryzwbj

A new Primer titled "Fungal Pathogens" published doi.org/10.1016/j.cub.… from Heitman lab at Duke - free access link here till late November: authors.elsevier.com/a/1bsBh3QW8Ru8…

Fun(gi)omics: Advanced and Diverse Technologies to Explore Emerging Fungal Pathogens and Define Mechanisms of Antifungal Resistance | mBio mbio.asm.org/content/11/5/e…

Closing 2020 with one last Cowen Lab publication in Nature Communications about a novel combination therapy to combat C. auris! So wonderful to work with so many fantastic people including BU-CMD Justin Nodwell and Christina Cuomo nature.com/articles/s4146…

Please pass along this opening for a Microbial Genomics Project Manager at the Broad Institute. The person in this role will join our Genomic Center for Infectious Disease, coordinating genomic studies across microbial systems.

Come join us at LifeMine and revolutionize drug discovery. Great opportunity for an innovative computational biologist to work on fungal genomics: linkedin.com/posts/michalis… #genomics #computationalbiology #datascience #drugdiscovery #hiring #jobs

Our paper on Candida auris Clade II genomic instability is now online at Genetics. Generating 12 long read assemblies of isolates across all five clades was key to characterizing structural variation and gene loss. Jose F. Muñoz Rory Welsh Jacquomo

Interested in applying genomic approaches to study human fungal pathogens? I am recruiting for a computational postdoc and two entry-level (BA/BS) computational scientist positions. Apply bit.ly/3tRoFt6 or bit.ly/3tQEnod. Email or DM questions, RTs appreciated.

Genome-Wide Analysis of Experimentally Evolved #CandidaAuris Reveals Multiple Novel Mechanisms of Multidrug Resistance mbio.asm.org/content/12/2/e…

It's rare that pathogens drive hosts to extinction- normally as hosts die, lower host density means less transmission. Our work out Nature Communications shows 1 explanation for dramatic European salamander population collapses associated with the fungus Bsal go.nature.com/3oCqkBH ..1/7

Excited to share- new manuscript from my lab (supported by SIDP YIRA) and an amazing team of collaborators, identifying the first mechanism of amphotericin B resistance in Candida auris, has been accepted for publication at CMI- Read the preprint now biorxiv.org/content/10.110…

#News for #investors and #media We are looking forward to teaming up with LifeMine to use their cutting-edge R&D platform, so together we can increase our chances of developing transformational new drugs for patients. businesswire.com/news/home/2022…

Fungi biotech LifeMine reveals 'dream scenario' GSK partnership, backed by Hal Barron and Tony Wood, plus a $175M fundraising $GSK fiercebiotech.com/biotech/lifemi…

Exciting day today! 1) $175 million Series C, led by Fidelity Management And Research Co 2) A deal with GSK with $70 million in upfront payments 3) New site in Basel, Switzerland By the way, we're hiring: lifeminetx.com/opportunities-… :) #biotechjobs #computationalbiology #Genomics